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Summary 
The purpose of these studies was to determine the intracellular  signal transduction pathways 
of bacterial products in murine macrophages from lipopolysaccharide (LPS)-responder C3H/HeN 
and LPS-nonresponder C3H/HeJ mice. Both LPS and synthetic lipopeptide CGP 31362 (LPP) 
induced production  of tumor  necrosis  factor  c~  (TNF-oe)  in  C3H/HeN  macrophages.  In 
C3H/HeJ macrophages,  however, TNF-oe was induced only by incubation with LPP. Both LPS 
and LPP induced tyrosine phosphorylation on proteins with apparent molecular masses of 39, 
41,  and  45  kD  (p35,  p41,  and  p45)  in  C3H/HeN  macrophages,  whereas  in  C3H/HeJ 
macrophages, tyrosine phosphorylation was induced only by LPP. 20-h incubation with LPS 
or LPP downregulated TNF-oL production/secretion and tyrosine phosphorylation in C3H/HeN 
macrophages induced by  additional LPS  or  LPP.  In  C3H/HeJ  macrophages,  however,  the 
downregulation of TNF-a production and tyrosine phosphorylation were observed only with 
LPP. Protein kinase assays, Western blotting analyses, phenyl-Sepharose  chromatography, and 
immunocomplex kinase assay suggested that p45 and p39 were similar or identical to mitogen- 
activated protein (MAP) kinase 1 and 2, respectively. Pretreatment of macrophages with LPS 
or LPP did not change the amount of kinase proteins but inhibited the stimulation of kinase 
activity by the agents. These data suggest that MAP kinases are among target proteins involved 
in the transduction of LPS and LPP signals that lead to activation of murine macrophages to 
produce/secrete TNF. 
N 
'atural and synthetic bacterial products, such as LPS and 
lipopeptide CGP 31362 (LPP) I, a synthetic analogue 
of a fragment of a lipoprotein from the outer wall of gram- 
negative bacteria,  are potent immunoregulatory agents (1). 
Either alone or in combination with IFN-~/or other cytokines, 
such agents activate macrophages to perform a variety of func- 
tions, such as lyse tumor cells, eliminate intracellular infec- 
tions, and secrete a plethora of distinct biologically active prod- 
ucts, such as TNF (2, 3).  The biochemical mechanisms of 
macrophage activation induced by the bacterial products are 
still not fully understood. Recently, activation of macrophages 
by LPS has been coupled with stimulation of calcium- and 
calmodulin-dependent protein kinase (4), protein kinase C 
(PKC)  (5),  and  pertussis  toxin-sensitive guanine nucleo- 
tide-binding proteins (G protein) (6). However,  inhibition 
of PKC in a macrophage cell line does not prevent LPS priming 
of the cells for enhanced arachidonic acid metabolism (7), 
1  Abbreviations used in this lmper: FBS, fetal bovine  serum;  LPP, lipopeptide 
GGP 31362; MAP kinase,  mitogen-activated  protein  kinase;  PEM, peritoneal 
exudate  macrophage;  PKC, protein  kinase  C; PTK.  protein  tyrosine  kinase. 
and many functions of LPS are not affected by treatment of 
macrophages with pertussis toxin (8). Moreover, downregu- 
lation ofintracellular PKC does not prevent macrophages from 
responding to LPS by secreting TNF and lysing some tumor 
cells (9). Collectively, these data suggest that additional signal- 
transducing pathways must participate in the macrophage ac- 
tivation process. 
In recent work from our laboratory,  we concluded that 
protein tyrosine kinase (PTK) activity is necessary albeit not 
suf~cient for LPS-induced tumoricidal activation of macro- 
phages. Specifically, the data demonstrated that protein tyro- 
sine phosphorylation is involved in this process (10). Activa- 
tion of MAP kinases, a family of serine/threonine protein 
kinases, by a variety of extracellular  stimuli plays a crucial 
role in cell differentiation and proliferation (11, 12). In this 
study, we determined whether phosphorylation-activation 
of MAP kinases is also involved in signaling pathways  for 
macrophage activation by bacterial  products, i.e., LPS and 
LPP. We tested this possibility by using macrophages from 
congenic LPS-responsive CoH/HeN and LPS-nonresponsive 
C3H/HeJ mice (13, 14). Tyrosine phosphorylation at several 
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tion of TNF-ol were observed in C3H/HeN macrophages 
incubated with either LPS or LPP, whereas only LPP was 
active in  C3H/HeJ  macrophages.  Pretreatment of macro- 
phages with LPS or LPP downregulated the phosphoryla- 
tion, activation of MAP kinases,  and production/secretion 
of TNF-o~. These findings suggest that MAP kinase activity 
is involved in macrophage activation by bacterial products. 
Materials and Methods 
Reagents.  Eagle's  MEM, HBSS, and fetal bovine serum (FBS) 
were  purchased from  M.  A.  Bioproducts  (Walkersville, MD). 
Phenol-extracted Salmonella LPS, phosphotyrosine, phosphothreo- 
nine, and phosphoserine were purchased from Sigma Chemicals 
(St. Louis, MO). Monoclonal antiphosphotyrosine (4G10), poly- 
clonal rabbit anti-MAP kinase 1 and 2 antibody, and synthetic MAP 
kinase substrate containing nine amino acids were obtained from 
Upstate Biotechnology, Inc. (Lake  Placid, NY). Anti-MAP kinase 
1 and 2 mAb (Z003) was purchased from Zymed Laboratories, Inc. 
(South San Francisco, CA).  [3H]TdK (sp act 2 Ci/mmol), BSA, 
and OVA were purchased from ICN Biomedicals,  Inc. (Costa Mesa, 
CA). PANSORBIN was obtained from Calbiochem-Novabiochem 
(La  Jolla, CA). Enhanced Chemiluminescence (ECL) Western blot- 
ting  detection  system, horseradish peroxidase conjugated  goat 
anti-mouse and anti-rabbit  IgG, and "y-[32p]ATP  (sp act >5000 
Ci/mmol)  were  purchased  from Amersham  Corp.  (Arlington 
Heights, IL). LPP, a synthetic analogue of  a fragment of a lipopro- 
tein from the outer wall of gram-negative bacteria, was the gift 
of Ciba-Geigy, Ltd. (Basel, Switzerland). Phenyl-Sepharose  was pur- 
chased from Pharmacia LKB (Piscataway, NJ). 
Mice.  Specific  pathogen-free female C3H/HeN and C3H/HeJ 
mice were purchased from the Animal Production Area, Frederick 
Cancer Research Facility (Frederick, MD). The mice were used 
when 8 wk of age. Animals were maintained in facilities approved 
by the American Association for Accreditation of Laboratory An- 
imal Care and in accordance with current  regulations and stan- 
dards of the United States Department of  Agriculture, the Depart- 
ment of Health and Human Services, and the National Institutes 
of Health. 
Collection and Cultivation of  Mouse Peritoneal  Exudate Macropha  ges 
(PEM).  PEM were collected by peritoneal lavage  from mice given 
an intraperitoneal injection of 1.5 ml of thioglycollate broth (Balti- 
more Biological Laboratories, Cockeysville, MD) 4 d before har- 
vest (15). The PEM were washed with Ca  2§  and Mg  2+ free PBS 
and  resuspended in  serum-free MEM,  and  10  s cells in  0.2  ml 
MEM were plated into 38-ram 2 wells of 96-well flat-bottomed 
plates (Microtest III; Falcon Plastics, Oxnard, CA). After 90 min, 
the wells were washed with Eagle's MEM to remove nonadherent 
cells. The resultant  macrophage monolayer was >98% pure ac- 
cording to morphologic and phagocytic  criteria. These cultures were 
then given supplemented  medium containing macrophage activators 
or other reagents as described below. 
In vitro Activation of  Macrophages and Production of TNF.  Purified 
cultures of mouse PEM were incubated at 37~  for 8-10 h with 
medium containing 1/~g/ml LPS or 0.01 #g/ml LPP. For a nega- 
tive control, we incubated macrophages in medium alone. After 
the incubation  period,  the culture  supernatants  were collected, 
filtered through a 0.2-#m filter, and added onto [3H]TdR-labeled 
L929 cell monolayers (104 cells/well). The cultures were washed 
and harvested 72 h later. TNF activity was calculated by the stan- 
dard curves plotted with human recombinant TNF-ol and expressed 
as pg/10  s macrophages. Neither LPS nor LPP were toxic nor did 
they increase the cytotoxic activity of TNF against the target cells. 
Determination of Tyrosine Phosphorylation by Western Blot Anal- 
ysis.  Macrophages  were treated as indicated in the legends to the 
figures. Western blotting was performed as previously described 
(10, 16). The cells were washed with PBS containing 1 mM so- 
dium orthovanadate, 5 mM EDTA, and scraped into lysis buffer 
A (1% Triton X-100, 20 mM Tris-HC1, pH 8.0, 137 mM NaC1, 
10% glycerol, 1 mM Na3VO4, 2 mM EDTA, 1 mM PMSF, 20 
#M leupeptin, 0.15 U/ml aprotinin), and placed on ice for 20 min. 
Triton  X-100-soluble protein  was  separated by centrifugation, 
diluted to I mg/ml in sample buffer (62.5 mM Tris-HC1, pH 6.8, 
2.3% SDS, 100 mM DTT, and 0.005%  bromphenol blue), and 
boiled. The proteins (15-20 #g/lane) were resolved on 10% SDS- 
PAGE and transferred onto 0.45 #m nitrocellulose  membranes. The 
filters were blocked with 3% BSA, 1% OVA in TBS (20 mM Tris- 
HCI, pH 7.5, 150 mM NaC1), probed with phosphotyrosine-specific 
mAb 4G10 (0.2 #g/ml), MAP kinase 1 and 2 specific  mAb Z003 
(0.1 #g/ml), or rabbit anti-rat MAP kinase antibody (0.2 #g/ml) 
in TTBS (0.1% Tween 20 in TBS), incubated with second anti- 
bodies in TTBS, and visualized by the ECL Western blotting de- 
tection  system. 
Immunoprecipitation of Macrophage Extracts.  Macrophages  at a 
density of 2  x  107 cells/100 mm phte were incubated in 5% FBS- 
Eagle's MEM or in 5% FBS-Eagle's MEM containing 1 #g/ml of 
LPS for 15 min. The monolayers were rinsed three times with PBS 
and scraped into 1 ml lysis buffer A. The lysates were precleared 
with  PANSORBIN  and  incubated  with  20  ~g/ml  of rabbit 
anti-MAP kinase antibody for 4 h or 20/~g/ml antiphosphotyro- 
sine mAb 4G10 for 3 h, and then with 20 #g/ml rabbit anti-mouse 
IgG for another 1 h at 4~  The immunocomplex was precipitated 
with PANSORBIN,  washed with a lysis  buffer A and kinase assay 
buffer, and then used for the MAP kinase assay. 
Hydrophobic Chromatography of Macrophage Extracts.  The meth- 
ods used for hydrophobic chromatography have been described in 
detail (17). After stimulation with 1 #g/ml LPS for 15 rain, mac- 
rophages were washed once and scraped into lysis  buffer B (25 mM 
Tris, pH 7.5, 25 mM NaC1, 40 mMp-nitrophenyl phosphate, 2 mM 
EGTA, 1 mM DTT, 0.2 mM PMSF), followed by brief sonication 
and centrifugation at 18,000 g for 30 min at 4oC. Ethylene glycol 
(final concentration 10%) was added to the supernatant fractions, 
and 1 ml of the extracts was immediately  mixed with 300/~1 phenyl- 
Sepharose and placed on ice for 5 min. The suspensions were then 
centrifuged and the supernatants removed. The phenyl-Sepharose 
was then successively  washed with 0.5 ml buffer B containing in- 
creasing concentrations of ethylene glycol (up to 60%). The su- 
pernatants were assayed  for MAP kinase activity or used for Western 
blotting analyses. 
MAP Kinase Assay.  MAP kinase activity was determined by 
a published procedure (18) with some modifications. A synthetic 
Peptide (APKTPGGRR) was phosphorylated  in a final  20-#1  volume 
of  kinase assay  buffer (12.5 mM MOPS, pH 7.2, 12.5 mM B-glycerol 
phosphate,  7.5  mM  MgC12, 0.5  mM  EGTA, 0.05  mM  NaF, 
2 mM DTT, 0.5 mM sodium vandate, and 25/~g/ml BSA) with 
2 mg/ml substrate and 50 #M "y[~2P]ATP  (1,000-2,000 cpm/pmol) 
for 15 min at 30~  The reaction was stopped by the addition of 
10 #1 15% TCA. After a 60-min incubation at 4~  the precipi- 
tates were removed by centrifugation,  and a 20-/~1 aliquot of the 
supernatant was spotted onto a phosphocellulose disc (model P81; 
Whatman Inc., Clifton,  NJ) and washed. The radioactivity as- 
sociated with the substrate Peptide was monitored.  MAP kinase 
activity was expressed as pmol/min/mg protein. 
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by LPS and LPP. Macrophages from C3H/HeN or C3H/HeJ mice were 
incubated in 5% FBS-Eagle's MEM (MED) or stimulated with LPS (1 
/xg/ml) or LPP (0.01/xg/ml) for 15 rain. The treated ceUs were washed 
and lysed in buffer A. The lysate was centrifuged at 14,000 rpm for 15 
rnin at 4~  Triton X-100-soluble proteins (15 Izg/lane} were separated 
on 10% SDS-PAGE, transferred to nitrocellulose, and probed with an- 
tiphosphotyrosine mAb 4G10 (0.2/~g/ml).  The immunoreactive bands 
were detected by incubating the blots with horseradish peroxidase-con- 
jugated goat anti-mouse IgG or anti-rabbit IgG, and visualized by the 
ECL Western blotting detection system. This is one representative  experi- 
ment of three. 
Results and Discussion 
LPS and LPP Induce Protein Tyrosine PhosFhorylation.  A 
15-rain  treatment  of macrophages  with  LPS (1  #g/ml)  or 
LPP (0.01/~g/ml) induced protein tyrosine phosphorylation 
at  three bands  of 39,  41,  and 45  kD  (p39,  p41,  and p45). 
In PEM,  some proteins with apparent molecular masses of 
50-170 kD were constitutively phosphorylated on tyrosine. 
The phosphorylation of these proteins was not significantly 
altered by LPS or LPP (Fig.  1). The signal detected by mAb 
4G10 was phosphotyrosine specific since it could be blocked 
by 2 mM phosphotyrosine but not by phosphothreonine or 
phosphoserine (data not shown). We have also recently shown 
that the induction of tyrosine phosphorylation by LPS and 
LPP is dose dependent and transient and can be blocked by 
the PTK inhibitors genistein, herbimycin A, and tyrphostin 
(10  and  our unpublished  data). 
The stimulus-specific induction of tyrosine phosphoryla- 
tion  on  p39,  p41,  and  p45  was  also  examined  in  LPS- 
unresponsive C3H/HeJ macrophages. As shown in Fig.  1 b, 
the  basic  pattern  of protein  tyrosine  phosphorylation  in 
C3H/HeJ  macrophages  was  similar  to  that  in  C3H/HeN 
macrophages.  However, in C3H/HeJ macrophages,  tyrosine 
phosphorylation of p39, p41, and p45 was only induced by 
LPP  (Fig.  1). 
Pretreatment of C3H/HeN macrophages for 20 h with ei- 
ther  LPS (0.1  /~g/ml)  or LPP  (0.001  Izg/ml)  significantly 
downregulated the tyrosine phosphorylation of p39, p41, and 
p45  normally induced by both LPS and LPP (Fig.  2).  The 
downregulation was dose dependent and could be achieved 
by pretreatment  with  as little as  1 ng/ml  LPS and  0.0001 
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Figure  2.  Downregulation  of protein  tyrosine phosphorylation by 
pretreatment  of LPS or  LPP. Macrnphages from  C3H/HeN  (A)  or 
C3H/HeJ (/3) mice were incubated for 20 h in medium (lanes 1-3), or 
medium containing 0.1 pg/ml LPS (lanes  4-6), or 0.001/~g/ml LPP (lanes 
7-9). The pretreated macrophages were then stimulated for 15 rain with 
1 I~g/ml LPS (lanes 2, 5, and 8) or 0.01 ~g/ml LPP (lanes 3, 6, and 9). 
The lysates  were prepared  and analyzed  by Western  blotting. Pretreatment 
of LPS or LPP did not alter the level of MAP kinase protein in macro- 
phages (C). CjH/HeN macrophages  were incubated for 20 h in medium, 
0.1 #g/ml LPS, or 0.001 #g/ml LPP. The treated cells were lysed  in buffer 
A. Triton X-100-soluble proteins (15 p.g/lane) were separated on 10% 
SDS-PAGE, transferred  onto nitrocellulose,  and probed with mAb against 
MAP kinase 1 and 2. This is one representative  experiment of three. 
ng/ml  LPP  (data  not  shown).  In  C3H/HeJ  macrophages, 
this downregulation could only be induced by pretreatment 
with  LPP (Fig.  2). 
The p45 and p39 Are Similar or Identical to MAP Kinase 
I and 2.  Since activation of MAP kinase requires tyrosine 
phosphorylation (12,  19) and LPS and LPP induce tyrosine 
phosphorylation  of some proteins with molecular weights 
Table  1.  Effects of LP$ or LPP Pretreatment on MAP Kinase 
Activation in CjH/HeN and CsH/HeJ Macrophages 
Stimulation 
Strain 
of mice  Pretreatment  Medium  LPS  LPP 
C3H/HeN  Medium*  3.6  +  0.7*  54.8  •  12.4  42.9  •  0.2 
LPS  2.0  +  0.6  2.7  •  1.5  13.5  •  0.5 
LPP  1.1  •  0.5  1.6  •  0.5  3.8  •  0.3 
C3H/HeJ  Medium  4.8  •  0.5  5.4  _+  0.2  58.2  •  4.2 
LPS  3.8  •  2.1  1.3  •  0.5  56.4  •  7.6 
LPP  3.0  •  1.0  1.0  •  0.5  2.0  •  0.3 
* Macrophages were incubated in medium, 0.1 #g/ml LPS, and 0.001 
/~g/ml LPP for 20 h. 
* 1/~g/ml LPS of 0.01/~g/ml LPP for 15 rain. The stimulated macro- 
phages were lysed in lysis buffer A. MAP kinase activity in the lysates 
was determined  and expressed  as pmol/min/mg protein +  ST) from dupli- 
cate assay tubes. This is one representative experiment of three. Figure 3.  (A) Phenyl-Sepharose  chromatography  of MAP kinase. Mac- 
rophages (2 x  107/plate)  were stimulated with LPS (1 #g/ml) for 15 min, 
followed by washing and lysing in buffer B. Ethylene glycol  was added 
to the extract at a final concentration of 10%. The extract (1 ml) was 
immediately  mixed  with 0.3 ml phenyl-Sepharose.  After  unbound  materials 
were removed, the phenyl-Sepharose  was washed with buffer B (0.5 ml 
each time) containing increasing concentrations of ethylene glycol  (up to 
60%). The supernatants were collected  by centrifugation, saved  for MAP 
kinase activity  assay, and for Western blotting analysis  with mAb against 
MAP kinase 1 and 2 (inset).  This is one representative  experiment of three. 
(B) Immunoprecipitation of MAP kinase activity. C3H/HeN macrophages 
were stimulated  with I #g/ml LPS for 15 rain and lysed  in buffer  A. The 
lysates  were  cleared  with PANSORBIN  and incubated  with either 20/~g/ml 
of antiphosphotyrosine mAb (4G10) for 3 h at 4~  and then 1 h incuba- 
tion with rabbit anti-mouse IgG, or with 20 #g/ml of rabbit anti-MAP 
kinase for 4 h. The immunocomplexes  were  precipitated  with PANSORBIN 
and washed with lysis  buffer A and kinase assay buffer. The MAP kinase 
activity  in the immunoeomplexes  was determined as described  in Materials 
and Methods. This is one representative experiment of two. 
similar to those of MAP kinases,  we tested whether LPS and 
LPP activated MAP kinases in macrophages. We determined 
MAP kinase activity by in vitro phosphorylation  of a syn- 
thetic substrate peptide (APILTPGGILK) derived from bo- 
vine myelin basic protein, which contains a consensus sequence 
for phosphorylation by p44map kinase (Pro-X-[Ser/Thr]-Pro) 
(18). Control macrophages exhibited low levels of MAP ki- 
nase activity. Treatment  with LPP resulted in a significant 
increase  in  MAP  kinase  activity  in  both  C3H/HeN  and 
C3H/HeJ macrophages,  whereas LPS stimulated MAP ki- 
nase  activity only in  C3H/HeN macrophages  (Table  1). 
The  possibility that  the  kinase  activity detected in  this 
system was derived from or was a result  of contamination 
by PKC, cAMP- or Ca2+-calmodulin-dependent  protein ki- 
nases was exculded by demonstrating that 2 mM EGTA and 
various concentrations (up to 1/xM) of synthetic peptide in- 
hibitor of cAMP-dependent protein kinase (20) did not alter 
kinase  activity (data not  shown). 
We also partially purified kinase activity by phenyl-Sepharose 
chromatography (17, 20, 21). In the lysate extracted with lysis 
buffer B,  MAP kinase  activity was 3125  +  124 cpm/9/~1 
lysate. The phenyl-Sepharose column bound all of the kinase 
activity at low ionic strengths,  and the activity in the lysate 
decreased to 74  _+  25 cpm/9/~1 sample.  As shown in Fig. 
3 A, the kinase activity was eluted by increasing concentra- 
tions of ethylene glycol. It appeared in the eluate of buffer 
B containing  25% ethylene glycol, maximal activity being 
duted by 55% ethylene glycol. In direct correlation with chro- 
matographic profile of the kinase activity, MAP kinase pro- 
tein was also eluted with increasing  concentrations  of eth- 
ylene glycol as detected by Western blotting with anti-MAP 
kinase mAb (Fig.  3 a). Ahhough a similar amount of MAP 
kinase protein was eluted in the lysate of untreated  macro- 
phages (data not  shown),  no MAP kinase activity was de- 
tected (Fig.  3 A).  Finally,  the MAP kinase activity in  the 
extracts was immunoprecipitated by both anti-MAP kinases 
and  antiphosphotyrosine  antibodies  (Fig.  3 B). 
A significant increase in MAP kinase activity was detect- 
able within 5 or 10 min after macrophages were stimulated 
with 0.01/xg/ml LPP or 1/~g/ml LPS, respectively (Fig. 4). 
Activity increased more than 10-fold over basal level at 10-15 
rain and decreased thereafter,  returning  to basal level at 60 
min.  LPP was more potent than LPS in activation of MAP 
kinase activity. An increase in the MAP kinase activity, de- 
termined after exposure for 15 min, could be detected by treat- 
ment with 10 ng/ml of LPS and 1 ng/ml LPP, respectively. 
Both time course and dose-related responses were strikingly 
similar to tyrosine phosphorylation induced by the same agents 
(data not shown).  The delayed response of macrophages to 
LPS may reflect a difference in the time required for ligand 
binding to its putative receptors, perhaps because LPS does 
not bind directly to its receptor  CD14 but rather  forms  a 
complex with a serum protein, LPS-binding protein (LBP), 
which in  turn  interacts  with  CD14  (22). 
To determine whether expression of MAP kinase protein 
correlates with tyrosine phosphorylation  of the kinase,  we 
analyzed macrophage lysates extracted with buffer A by using 
antiphosphotyrosine  mAb and antibodies against MAP ki- 
nase  1  and  2  in parallel  (Fig.  5).  Although  tyrosyl phos- 
phorylated p39, p41, and p45 were detectable only in LPS- 
and LPP-treated groups as described above, the same amount 
of proteins migrated at distances corresponding to MAP ki- 
nase 1 (p45) and MAP kinase 2 (p39) that were detected by 
both monodonal and polyclonal anti-MAP kinase antibodies 
in the extracts from medium (control), LPS-, and LPP-treated 
macrophages  (Fig.  5). These resuhs indicate that  MAP ki- 
nases  are constitutively expressed in macrophages  and that 
the regulation of kinase activity in macrophages most likely 
occurs at posttranscriptional  levels, mainly at phosphoryla- 
tion and/or dephosphorylation.  This is consistent with our 
findings that blocking protein synthesis with cycloheximide 
does not  affect tyrosine phosphorylation  of p39,  p41,  and 
p45 or MAP kinase activity stimulated by LPS or LPP (data 
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Figure 4.  (A) Time course of MAP kinase activation in macrophages 
by LPS and LPP. C3H/HeN macrophages were treated with 1 #g/ml LPS 
or 0.01 #g/ml LPP for different times. The treated cells were then lysed 
in buffer A. The MAP kinase activity in the extract was determined and 
expressed as pmol/min/mg  protein  _+ SD from duplicate assay  tubes. This 
is one representative experiment of two.  (B) Dose-response  of MAP ki- 
nase activation in macrophages by LPS and LPP. C3H/HeN macrophages 
were treated for 15 min with various concentrations of LPS or LPP. The 
treated cells were lysed in buffer A, MAP kinase activity in the lysates 
was determined and expressed as pmol/min/mg  protein  _+ SD from dupli- 
cate assay tubes. This is one representative experiment  of two. 
Figure 5.  Detection  of MAP kinase protein in murine macrophages 
by Western  blot analysis. C3H/HeN  macrophages  were  incubated  in 
medium (lane 1), stimulated for 15 rain with 1/~g/ml of LPS (lane 2), 
or 0.01/~g/ml of LPP (lane 3).  The Triton X-100-soluble proteins  (15 
~g/ml) were separated on 10% SDS-PAGE, transferred onto nitrocellu- 
lose, probed with 0.2 #g/ml antiphosphotyrosine  mAb 4G10 (Upstate 
Biotechnology, Inc.) (A, ~Y/'I  o, 0.1/*g/ml anti-MAP kinase mAb Z003 
(Zymed Laboratories, Inc.) (B, czMAP kinase raAb), or 0.2 I~g/ml poly- 
clonal anti-MAP kinase Ab (Upstate Biotechnology, Inc.) (C, ~xlVIAP  ki- 
nase [rabbit  A b]), and visualized by using the ECL Western blotting detec- 
tion system. This is one representative experiment  of two. 
do express normal levels of the potential LPS receptor as 
demonstrated by LPS binding (27) and immunocytochem- 
istry (28).  The possibility that the downregulation is due 
to depletion of MAP kinase per se is also ruled out. In con- 
trast with MAP kinase activity, neither the pretreatment nor 
the stimulation of LPS or LPP markedly changed MAP ki- 
not shown). Moreover,  pretreatment of macrophages with 
LPS or LPP blocked MAP kinase activation but had no effect 
on the expression of the MAP kinase proteins (see below). 
These results are in agreement with findings in the M phase 
of the Xenopus cell  cycle (23).  The p41  detected by  an- 
tiphosphotyrosine mAb could not be probed by anti-MAP 
kinase antibodies (Fig. 5), and its identity is not dear. It might 
be another member of the MAP kinase family that cannot 
be detected by the antibodies we used or it might be a MAP 
kinase activator that regulates MAP kinase activity (24). 
Consistent with the observations in tyrosine phosphory- 
lation, a 20-h pretreatment of macrophages from both strains 
of mice with LPP (0.001 #g/ml) significantly downregulated 
MAP kinase activation by LPS or LPP. Pretreatment with 
LPS (0.1 #g/ml) also blocked MAP kinase activation induced 
by both stimuli but was only effective in C3H/HeN mac- 
rophages (Table 1). Downregulation of kinase activation has 
been attributed to depletion of receptors by ligand binding 
(25,  26).  However,  if LPS and LPP shared a receptor,  then 
pretreatment with LPS should have contributed to the reduc- 
tion of MAP kinase activation in C3H/HeJ macrophages. 
Although these macrophages do not respond to LPS, they 
Table  2.  Effects of LPS or LPP Pretreatment on  TNF 
Production/Secretion by C3H/HeN and C~I/HeJ Macrophages 
Stimulation 
Strain 
of mice  Pretreatment  Medium  LPS  LPP 
C3H/HeN  Medium*  2  _+  4*  145  _+  5  169  _+  25 
LPS  12  _+  1  6  _+  3  51  _+  18 
LPP  8  _+  4  11  _+  3  7  _+  3 
C3H/HeJ  Medium  3  +  2  3  _+  0  153  +  18 
LPS  5  +  2  4  +  1  173  •  15 
LPP  4  +_  1  3  +_  0  4  +_  1 
* Macrophages were  incubated  in medium, 0.1  /xg/ml LPS, or 0.001 
/~g/ml LPP for 20 h. 
1/zg/ml LPS or 0.01/,~g/ml LPP for 8 h. The supernatants were ad- 
ded to [3H]TdR-labeled L929 cells at 1:2 dilution. Cytotoxicity was de- 
termined 72 h later. The data were expressed as pg/10  s macrophages  _+ 
SD from triplicate cultures. This is one representative experiment of four. 
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or C3H/HeJ (data not shown) macrophages.  Taken together, 
our data suggest that the downregulation occurs at stages 
between receptor binding and activation of MAP kinase (24). 
Correlation  between MAP Kinase Activation and Induction of 
TNF Production~Secretion.  Macrophages from C3H/HeN or 
C3H/HeJ mice were incubated in medium, LPS, or LPP for 
20 h (pretreatment) and then stimulated with the same agents 
at  10 times the dose for 8 h. TNF activity in the culture 
supernatants was measured by a bioassay with L929 as target 
cells (Table 2). Culture supernatants from control PEM con- 
tained low levels of TNF activity. After incubation with 1 
#g/ml LPS or 0.01  /zg/ml LPP,  C3H/HeN  macrophages 
secreted/produced significantly higher amounts of TNF. In 
C3H/HeJ  macrophages,  similar  amounts  of TNF  secre- 
tion/production were induced only by LPP.  In agreement 
with tyrosine phosphorylation and MAP kinase activation, 
exposure of C3H/HeN macrophages  to LPS or LPP for 20 h 
downregulated TNF secretion/production induced by either 
LPS or LPP.  Similarly,  the response  in C3H/HeJ macro- 
phages was downregulated only by pretreatment with LPP. 
These data indicate that activation of MAP kinase is directly 
correlated with induction of TNF production/secretion. 
In summary, we provide evidence that MAP kinases are 
among the target proteins of  bacterial products and that acti- 
vation of MAP kinases play an important role in the interac- 
tion of macrophages with bacteria and/or their products. Our 
data therefore extend observations derived in a murine mac- 
rophage tumor cell line (29).  Activation of MAP kinase by 
LPS and LPP may result from different mechanisms whose 
exact nature is still unclear. The system described here should 
be useful for such an investigation. 
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